Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 8
Submit an article Journal homepage
833
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs

Enrique M OcioDepartment of Hematology, University Hospital of Salamanca, P. San Vicente, 58-182, 37007 Salamanca, Spain+34 923 291384; +34 923 294624; [email protected]
, MD PhD,
Maria-Victoria MateosCancer Research Center (IBMCC-CSIC), University of Salamanca, Salamanca, Spain
&
Jesus F San-MiguelInstitute of Biomedical Research of Salamanca (IBSAL), Spain
Pages 1075-1087 | Published online: 24 May 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.